Local treatment of tumor-bearing mice with CTLA-4 functional antibody in a slow-release formulation is extremely effective in activating an endogenous tumor-specific CD8+ T cell response, capable of tumor eradication [34]. This evidence concerns the gene CD8A and neoplasm.